Actigall and Bacteraemia - a phase IV clinical study of FDA data

Summary:

Bacteraemia is reported as a side effect among people who take Actigall (ursodiol), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Acyclovir, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Bacteraemia when taking Actigall. It is created by eHealthMe based on reports of 2,122 people who have side effects when taking Actigall from the FDA, and is updated regularly.

What is Actigall?

Actigall has active ingredients of ursodiol. It is often used in gallstones. eHealthMe is studying from 2,162 Actigall users. Check the latest studies of Actigall.

What is Bacteraemia?

Bacteraemia (presence of bacteria in the blood) is found to be associated with 1,070 drugs and 1,504 conditions by eHealthMe. Check the latest studies of Bacteraemia.

On Jan, 27, 2026

2,122 people reported to have side effects when taking Actigall.
Among them, 15 people (0.71%) have Bacteraemia.

Among these 15 people:

How long have people been on Actigall when they have Bacteraemia? *

What is the gender of people who have Bacteraemia when taking Actigall? *

female: 20 %
male: 80 %

What is the age of people who have Bacteraemia when taking Actigall? *

What are other drugs people take besides Actigall? *

What are other side effects people have besides Bacteraemia? *

Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 3 people, 20.00%
Fever: 3 people, 20.00%
Mastoiditis (infection of mastoid bone): 3 people, 20.00%
Osteomyelitis (infection of bone): 3 people, 20.00%
Cellulitis (infection under the skin): 3 people, 20.00%
Weight Decreased: 2 people, 13.33%
Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 2 people, 13.33%
Weakness: 2 people, 13.33%
Hypotension (abnormally low blood pressure): 2 people, 13.33%
Infection: 2 people, 13.33%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 5 people, 33.33%
Upper Respiratory Tract Infection: 3 people, 20.00%
Blood Alkaline Phosphatase Increased: 3 people, 20.00%
Constipation: 3 people, 20.00%
High Blood Pressure: 3 people, 20.00%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 20.00%
Hyperbilirubinaemia (excess of bilirubin in the blood): 3 people, 20.00%
Pain: 3 people, 20.00%
Otitis (ear infection): 3 people, 20.00%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Actigall and have Bacteraemia?

- Check whether Bacteraemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Actigall:

Actigall (2,162 reports)

Bacteraemia treatments and more:

Bacteraemia (15,996 reports)

Browse all side effects of Actigall:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bacteraemia:

Bacteraemia (1,070 drugs)

Browse all the conditions that are associated with Bacteraemia:

Bacteraemia (1,504 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ursodiol (the active ingredients of Actigall) and Actigall (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.